170 related articles for article (PubMed ID: 7777382)
1. [Nature and physicochemical and biological properties of non conventional transmissible agents or prions: consequences for public health].
Dormont D
Pathol Biol (Paris); 1995 Feb; 43(2):124-36. PubMed ID: 7777382
[TBL] [Abstract][Full Text] [Related]
2. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
3. Agents that cause transmissible subacute spongiform encephalopathies.
Dormont D
Biomed Pharmacother; 1999; 53(1):3-8. PubMed ID: 10221161
[TBL] [Abstract][Full Text] [Related]
4. How to limit the spread of Creutzfeldt-Jakob disease.
Dormont D
Infect Control Hosp Epidemiol; 1996 Aug; 17(8):521-8. PubMed ID: 8875297
[TBL] [Abstract][Full Text] [Related]
5. [Human transmissible subacute spongiform encephalopathy].
Dormont D
Bull Acad Natl Med; 1994 May; 178(5):887-903; discussion 904-5. PubMed ID: 7953896
[TBL] [Abstract][Full Text] [Related]
6. [Unconventional transmissible agents or prions].
Dormont D
Rev Prat; 1994 Apr; 44(7):882-7. PubMed ID: 7939297
[TBL] [Abstract][Full Text] [Related]
7. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
8. Implications of prion diseases for neurosurgery.
Blättler T
Neurosurg Rev; 2002 Aug; 25(4):195-203. PubMed ID: 12172722
[TBL] [Abstract][Full Text] [Related]
9. [The non-conventional transmissible agents at the origin of transmissible subacute spongiform encephalopathies].
Dormont D
Therapie; 1998; 53(2):93-100. PubMed ID: 9773107
[TBL] [Abstract][Full Text] [Related]
10. Prions and prion diseases: fundamentals and mechanistic details.
Ryou C
J Microbiol Biotechnol; 2007 Jul; 17(7):1059-70. PubMed ID: 18051314
[TBL] [Abstract][Full Text] [Related]
11. [Significance of prion protein in transmission of prions and in pathogenesis of spongiform encephalopathies].
Raeber AJ; Klein MA; Frigg R; Brandner S; Blättler T; Aguzzi A
Wien Med Wochenschr; 1998; 148(4):74-7. PubMed ID: 9611346
[TBL] [Abstract][Full Text] [Related]
12. Prion diseases: pathogenesis and public health concerns.
Dormont D
FEBS Lett; 2002 Oct; 529(1):17-21. PubMed ID: 12354606
[TBL] [Abstract][Full Text] [Related]
13. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
14. BSE: can we predict the future?
Plum J
Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
[TBL] [Abstract][Full Text] [Related]
15. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
Bastian FO; Fermin CD
Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
[TBL] [Abstract][Full Text] [Related]
16. Transmissible spongiform encephalopathies.
Liemann S; Glockshuber R
Biochem Biophys Res Commun; 1998 Sep; 250(2):187-93. PubMed ID: 9753605
[TBL] [Abstract][Full Text] [Related]
17. Prions and peripheral nerves: a deadly rendezvous.
Heikenwalder M; Julius C; Aguzzi A
J Neurosci Res; 2007 Sep; 85(12):2714-25. PubMed ID: 17393538
[TBL] [Abstract][Full Text] [Related]
18. The transmissible spongiform encephalopathies.
Lasmézas CI
Rev Sci Tech; 2003 Apr; 22(1):23-36. PubMed ID: 12793772
[TBL] [Abstract][Full Text] [Related]
19. [Comments on present-day spread and epidemiology of BSE and prion diseases].
Bodemer W; Kaup FJ
Gesundheitswesen; 2004 Feb; 66 Suppl 1():S21-5. PubMed ID: 14770333
[TBL] [Abstract][Full Text] [Related]
20. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
